Empagliflozin in Diuretic Refractory Ascites
NCT05013502
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Cirrhosis
Ascites
Ascites Hepatic
Sodium-Glucose Transporter 2 Inhibitors
Interventions
DRUG:
Empagliflozin 10 MG
Sponsor
Stanford University